The annual general meeting is scheduled for 28 November 2011. (see Appendix 4E)
You can email Dr Steven Mercer ([email protected]) for your investor's enquiries and he will reply.
It is expected that announcements on commercial deal, final EU clinical results and USA device classification would happen at the end of September or early October. Please be patient and hope for the best.
The annual general meeting is scheduled for 28 November 2011....
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)